vs

Side-by-side financial comparison of Astera Labs, Inc. (ALAB) and Sabra Health Care REIT, Inc. (SBRA). Click either name above to swap in a different company.

Astera Labs, Inc. is the larger business by last-quarter revenue ($270.6M vs $221.8M, roughly 1.2× Sabra Health Care REIT, Inc.). Sabra Health Care REIT, Inc. runs the higher net margin — 18.4% vs 16.6%, a 1.8% gap on every dollar of revenue. On growth, Astera Labs, Inc. posted the faster year-over-year revenue change (91.8% vs 20.8%). Over the past eight quarters, Astera Labs, Inc.'s revenue compounded faster (103.6% CAGR vs 12.2%).

Astera Labs, Inc. is an American fabless semiconductor manufacturer and artificial intelligence company. The company specializes in designing high-speed connectivity solutions for data centers and AI infrastructure. The company has been listed on the Nasdaq since March 2024.

Sabra Health Care REIT, Inc. is a specialized real estate investment trust that owns, manages, and invests in a diverse portfolio of healthcare real estate assets. Its core holdings include senior housing facilities, skilled nursing centers, specialty hospital properties, and medical office buildings across the United States, serving key segments of the growing senior care and healthcare delivery markets.

ALAB vs SBRA — Head-to-Head

Bigger by revenue
ALAB
ALAB
1.2× larger
ALAB
$270.6M
$221.8M
SBRA
Growing faster (revenue YoY)
ALAB
ALAB
+71.0% gap
ALAB
91.8%
20.8%
SBRA
Higher net margin
SBRA
SBRA
1.8% more per $
SBRA
18.4%
16.6%
ALAB
Faster 2-yr revenue CAGR
ALAB
ALAB
Annualised
ALAB
103.6%
12.2%
SBRA

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ALAB
ALAB
SBRA
SBRA
Revenue
$270.6M
$221.8M
Net Profit
$45.0M
$40.8M
Gross Margin
75.6%
Operating Margin
24.7%
Net Margin
16.6%
18.4%
Revenue YoY
91.8%
20.8%
Net Profit YoY
82.0%
1.3%
EPS (diluted)
$0.25

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALAB
ALAB
SBRA
SBRA
Q1 26
$221.8M
Q4 25
$270.6M
$211.9M
Q3 25
$230.6M
$190.0M
Q2 25
$191.9M
$189.2M
Q1 25
$159.4M
$183.5M
Q4 24
$141.1M
$182.3M
Q3 24
$113.1M
$178.0M
Q2 24
$76.8M
$176.1M
Net Profit
ALAB
ALAB
SBRA
SBRA
Q1 26
$40.8M
Q4 25
$45.0M
$27.2M
Q3 25
$91.1M
$22.5M
Q2 25
$51.2M
$65.5M
Q1 25
$31.8M
$40.3M
Q4 24
$24.7M
$46.7M
Q3 24
$-7.6M
$29.8M
Q2 24
$-7.5M
$24.0M
Gross Margin
ALAB
ALAB
SBRA
SBRA
Q1 26
Q4 25
75.6%
Q3 25
76.2%
Q2 25
75.8%
Q1 25
74.9%
Q4 24
74.0%
Q3 24
77.7%
Q2 24
77.9%
Operating Margin
ALAB
ALAB
SBRA
SBRA
Q1 26
Q4 25
24.7%
12.3%
Q3 25
24.0%
11.4%
Q2 25
20.7%
34.5%
Q1 25
7.1%
22.1%
Q4 24
0.1%
25.9%
Q3 24
-7.9%
16.5%
Q2 24
-31.7%
13.8%
Net Margin
ALAB
ALAB
SBRA
SBRA
Q1 26
18.4%
Q4 25
16.6%
12.8%
Q3 25
39.5%
11.9%
Q2 25
26.7%
34.7%
Q1 25
20.0%
22.0%
Q4 24
17.5%
25.6%
Q3 24
-6.7%
16.7%
Q2 24
-9.8%
13.6%
EPS (diluted)
ALAB
ALAB
SBRA
SBRA
Q1 26
Q4 25
$0.25
$0.11
Q3 25
$0.50
$0.09
Q2 25
$0.29
$0.27
Q1 25
$0.18
$0.17
Q4 24
$1.23
$0.20
Q3 24
$-0.05
$0.13
Q2 24
$-0.05
$0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALAB
ALAB
SBRA
SBRA
Cash + ST InvestmentsLiquidity on hand
$167.6M
$116.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.4B
$2.8B
Total Assets
$1.5B
$5.6B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALAB
ALAB
SBRA
SBRA
Q1 26
$116.5M
Q4 25
$167.6M
$71.5M
Q3 25
$140.4M
$200.6M
Q2 25
$162.3M
$95.2M
Q1 25
$86.4M
$22.7M
Q4 24
$79.6M
$60.5M
Q3 24
$126.1M
$63.0M
Q2 24
$421.1M
$36.4M
Total Debt
ALAB
ALAB
SBRA
SBRA
Q1 26
Q4 25
$2.5B
Q3 25
$2.6B
Q2 25
$2.5B
Q1 25
$2.4B
Q4 24
$2.4B
Q3 24
$2.5B
Q2 24
$2.4B
Stockholders' Equity
ALAB
ALAB
SBRA
SBRA
Q1 26
$2.8B
Q4 25
$1.4B
$2.8B
Q3 25
$1.3B
$2.8B
Q2 25
$1.1B
$2.7B
Q1 25
$1.0B
$2.7B
Q4 24
$964.8M
$2.7B
Q3 24
$889.6M
$2.7B
Q2 24
$845.3M
$2.8B
Total Assets
ALAB
ALAB
SBRA
SBRA
Q1 26
$5.6B
Q4 25
$1.5B
$5.5B
Q3 25
$1.4B
$5.6B
Q2 25
$1.3B
$5.3B
Q1 25
$1.1B
$5.2B
Q4 24
$1.1B
$5.3B
Q3 24
$983.1M
$5.4B
Q2 24
$915.5M
$5.4B
Debt / Equity
ALAB
ALAB
SBRA
SBRA
Q1 26
Q4 25
0.90×
Q3 25
0.92×
Q2 25
0.91×
Q1 25
0.89×
Q4 24
0.88×
Q3 24
0.90×
Q2 24
0.89×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALAB
ALAB
SBRA
SBRA
Operating Cash FlowLast quarter
$95.3M
$98.4M
Free Cash FlowOCF − Capex
$76.6M
FCF MarginFCF / Revenue
28.3%
Capex IntensityCapex / Revenue
6.9%
Cash ConversionOCF / Net Profit
2.12×
2.41×
TTM Free Cash FlowTrailing 4 quarters
$281.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALAB
ALAB
SBRA
SBRA
Q1 26
$98.4M
Q4 25
$95.3M
$348.6M
Q3 25
$78.2M
$100.0M
Q2 25
$135.4M
$81.0M
Q1 25
$10.5M
$80.3M
Q4 24
$39.7M
$310.5M
Q3 24
$63.5M
$97.7M
Q2 24
$29.8M
$80.1M
Free Cash Flow
ALAB
ALAB
SBRA
SBRA
Q1 26
Q4 25
$76.6M
Q3 25
$65.9M
Q2 25
$133.3M
Q1 25
$6.0M
Q4 24
$24.3M
Q3 24
$46.8M
Q2 24
$28.5M
FCF Margin
ALAB
ALAB
SBRA
SBRA
Q1 26
Q4 25
28.3%
Q3 25
28.6%
Q2 25
69.5%
Q1 25
3.7%
Q4 24
17.2%
Q3 24
41.4%
Q2 24
37.1%
Capex Intensity
ALAB
ALAB
SBRA
SBRA
Q1 26
Q4 25
6.9%
Q3 25
5.3%
Q2 25
1.1%
Q1 25
2.8%
Q4 24
10.9%
Q3 24
14.8%
Q2 24
1.7%
Cash Conversion
ALAB
ALAB
SBRA
SBRA
Q1 26
2.41×
Q4 25
2.12×
12.80×
Q3 25
0.86×
4.44×
Q2 25
2.64×
1.24×
Q1 25
0.33×
1.99×
Q4 24
1.61×
6.65×
Q3 24
3.28×
Q2 24
3.34×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ALAB
ALAB

Segment breakdown not available.

SBRA
SBRA

Resident fees and services$116.7M53%
Rental and related revenues (1)$95.0M43%
Other$10.0M5%

Related Comparisons